Anime loves bending rules, and gender-bender shows prove it best. From cursed transformations to chaotic body swaps, these ...

Gintama has the most, loud and unapologetic female characters who shatter Shonen anime tropes for female characters.

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

ATLANTA — The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of treating it also puts the health care system in a bind. Dr. Scott Kahan ...

Some experts believe that anyone could benefit from GLP-1 medications, as the popular drugs have become more widespread and accessible. Others, however, warn that the decision to take the diabetes and ...

After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the top spot at an obesity-focused biotech. Boulton has been named CEO of ...

Novo Nordisk NOVO.B-0.76%decrease; red down pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

Watching an anime can be exciting, but playing in a world that carries the same style, attitude, and emotional punch is even more exciting. That’s where anime-style games come in. They mix bold art, ...

Scientists found that certain molecules made by gut bacteria travel to the liver and help control how the body uses energy. These molecules change depending on diet, genetics, and shifts in the ...

Pfizer Inc. pulled off a comeback win, beating out Danish drug giant Novo Nordisk to acquire obesity drug developer Metsera Inc. in a deal that values the biotechnology company at up to $9.1 billion.

Both crises share common roots and solutions, researchers say. The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping new ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...